Lilly Named One of America's Best Adoption-Friendly Workplaces

INDIANAPOLIS, Sept. 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has been named to the 2011 Best Adoption-Friendly Workplaces List by the Dave Thomas Foundation for Adoption. This is the fifth consecutive year that Lilly has been ranked in the top 100.

Rankings for the Best Adoption-Friendly Workplaces List are determined by an analysis of a company's benefits to employees who adopt, such as financial reimbursement and paid leave. The Foundation compiled the results from its annual survey of U.S. employers and partnered with Employee Benefit News to announce the winners.

Today, more than 107,000 children are available for adoption in U.S. foster care. Each year, nearly 26,000 of these youth will end up leaving the system when they turn 18 without a family. The release of the fifth annual Best Adoption-Friendly Workplaces List helps the Foundation increase foster care adoption awareness while celebrating those businesses that support adoptive families.

In addition to ranking the top 100 adoption-friendly workplaces, the Foundation also recognized the top 10 companies by size and recognized the leaders of each industry. To view all of the honorees, visit www.DaveThomasFoundation.org.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About the Dave Thomas Foundation for Adoption

The Dave Thomas Foundation for Adoption is America's only nonprofit public charity dedicated exclusively to finding permanent homes for the 107,000 children waiting in foster care to be adopted. Created by Wendy's® founder, Dave Thomas, who was adopted, the Foundation implements results-driven national signature programs, foster care adoption awareness initiatives and research-based advocacy efforts. To learn more, visit www.DaveThomasFoundation.org or call 1-800-ASK-DTFA.
C-LLY

(Logo:  http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Suggested Articles

Merck's Keytruda has new long-term survival results that the drugmaker hopes will help bolster its position in first-line NSCLC.

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.